Adagio Medical Holdings, Inc Common Stock (ADGM) - Total Assets
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) holds total assets worth $43.25 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Adagio Medical Holdings, Inc Common Stoc service its debt to assess how comfortably operating cash covers total debt obligations.
Adagio Medical Holdings, Inc Common Stock - Total Assets Trend (2020–2025)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's total assets have evolved over time, based on quarterly financial data. See ADGM net asset value for net asset value and shareholders' equity analysis.
Adagio Medical Holdings, Inc Common Stock - Asset Composition Analysis
Current Asset Composition (December 2025)
Adagio Medical Holdings, Inc Common Stock's total assets of $43.25 Million consist of 46.4% current assets and 53.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 39.6% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $1.67 Million | 3.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $6.97 Million | 16.1% |
| Goodwill | $13.97 Million | 32.3% |
Asset Composition Trend (2020–2025)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ADGM stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adagio Medical Holdings, Inc Common Stock's current assets represent 46.4% of total assets in 2025, an increase from 4.1% in 2020.
- Cash Position: Cash and equivalents constituted 39.6% of total assets in 2025, up from 0.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 32.3% of total assets.
Adagio Medical Holdings, Inc Common Stock Competitors by Total Assets
Key competitors of Adagio Medical Holdings, Inc Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Adagio Medical Holdings, Inc Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.44 | 3.27 | 0.52 |
| Quick Ratio | 2.24 | 2.93 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $11.85 Million | $17.59 Million | $-6.24 Million |
Adagio Medical Holdings, Inc Common Stock - Advanced Valuation Insights
This section examines the relationship between Adagio Medical Holdings, Inc Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.74 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -10.7% |
| Total Assets | $43.25 Million |
| Market Capitalization | $8.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Adagio Medical Holdings, Inc Common Stock's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Adagio Medical Holdings, Inc Common Stock's assets decreased by 10.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Adagio Medical Holdings, Inc Common Stock (2020–2025)
The table below shows the annual total assets of Adagio Medical Holdings, Inc Common Stock from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $43.25 Million | -10.72% |
| 2024-12-31 | $48.45 Million | +609.86% |
| 2023-12-31 | $6.83 Million | -21.52% |
| 2022-12-31 | $8.70 Million | -59.44% |
| 2021-12-31 | $21.44 Million | +50409.95% |
| 2020-12-31 | $42.45K | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more